Nereus Pharmaceuticals, Inc. Raises $20 Million
6/23/2010 7:26:09 AM
More...
|
Nereus Pharmaceuticals, Inc. Completes Enrollment of Phase 2 ADVANCE Clinical Trial of Plinabulin in Non-Small Cell Lung Cancer
6/22/2010 8:48:47 AM
More...
|
Nereus Pharmaceuticals, Inc. Presents Positive Interim Data from the ADVANCE Study, a Randomized Phase 2 Clinical Trial of Plinabulin (NPI-2358) in Non-Small Cell Lung Cancer at the 2009 EORTC-NCI-AACR Conference
11/23/2009 9:52:24 AM
More...
|
Nereus Pharmaceuticals, Inc. Initiates ADVANCE, a Randomized Phase 2 Clinical Trial of NPI-2358 in Non-Small Cell Lung Cancer
3/23/2009 8:34:37 AM
More...
|
Nereus Pharmaceuticals, Inc. Initiates Combination Clinical Trial for Proteasome Inhibitor NPI-0052 in Solid Tumors
4/18/2008 8:44:52 AM
More...
|
Nereus Pharmaceuticals, Inc. Initiates Clinical Trial of NPI-2358 in Non-Small Cell Lung Cancer Following Encouraging Phase 1 Data
3/20/2008 6:43:56 AM
More...
|
Nereus Pharmaceuticals, Inc.'s NPI-0052 Named One of the Industry's Top Ten Unpartnered Oncology Drug Candidates
10/16/2007 8:17:55 AM
More...
|
Nereus Pharmaceuticals, Inc. Raises $45 Million in Series D-2 Financing
8/9/2007 7:36:29 AM
More...
|
The Multiple Myeloma Research Consortium and Nereus Pharmaceuticals, Inc. Initiate Clinical Trial Investigating NPI-0052 to Treat Multiple Myeloma
4/16/2007 11:44:26 AM
More...
|
Nereus Pharmaceuticals, Inc. to Present Data at the American Association for Cancer Research 2007 Annual Meeting
4/9/2007 1:40:45 PM
More...
|
|